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Abstract
The precise effects of protein intake on fractional synthesis rate (FSR) of muscle protein are still under debate. The sample size of these studies
was small and the conclusions in young and elderly subjects were inconsistent. To assess the effect of dietary protein intake on the FSR level,
we conducted a meta-analysis of controlled protein intake trials. Random-effects models were used to calculate the weighted mean differences (WMDs).
Ten studies were included and effects of short-term protein intake were evaluated. In an overall pooled estimate, protein intake significantly increased
the FSR (20 trials, 368 participants; WMD: 0.025%/h; 95%CI: 0.019-0.031; P< 0.0001). Meta-regression analysis suggested that the protein dose
was positively related to the effect size (regression coefficient = 0.108%/h; 95%CI: 0.035, 0.182; P= 0.009). A subgroup analysis indicated that 
protein intake significantly increased FSR when the protein dose was ≤0.80 g/kg BW (16 trials, 308 participants; WMD: 0.027%/h; 95%CI: 0.019-0.031;
P< 0.0001), but did not affect FSR when the protein dose was > 0.80 g/kg BW (4 trials, 60 participants; WMD: 0.016%/h; 95%CI: 0.004-0.029;
P= 0.98). In conclusion, this study is the first integrated results showing that a short-term protein intake is effective at improving the FSR of muscle
protein in the healthy elderly as well as young subjects. This beneficial effect seems to be dose-dependent when the dose levels of protein range
from 0.08 to 0.80 g/kg BW. 
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Introduction5)
Aging is accompanied by changes in body composition with 
a progressive loss of muscle mass, strength, and metabolic 
function [1-4]. A net loss of muscle with aging is the result of 
a chronic imbalance between muscle protein synthesis and 
breakdown. The age-related loss of muscle protein synthesis is 
referred as sarcopenia [5-9]. Chronic muscle loss is estimated 
to affect 30% of people older than 60 y and may affect > 50% 
of those older than 80 y [9-12]. Sarcopenia is associated with 
a 3- to 4-fold increased likelihood of disability, which in turn 
is associated with substantial socioeconomic and health care 
spending. One analysis estimated that in 2000, sarcopenia was 
responsible for $18.5 billion in health care costs [9,12]. 
Muscle plays a central role in whole-body protein metabolism 
[4]. Muscle protein metabolism alternates between periods of net 
catabolism in the postabsorptive state and net anabolism in the 
postprandial states, with the latter being primarily a result of 
changes in muscle protein synthesis [13,14]. Protein or amino 
acids are potent stimulators of muscle protein synthesis in both 
the young and elderly [14,15,16-24]. Many reports suggest that 
protein or amino acids may be useful at improving the fractional 
synthesis rate (FSR) of muscle protein in essential tissues and 
organs of human body [4,8,9,15,25-31]. Above all, it is important 
to supply a source of shortage protein, which increases the muscle 
mass and strength through protein synthesis. 
However, a study of net balance was found to be similar in 
young and elderly men and could not explain the loss of muscle 
that occurs with age [32]. No studies have shown the integrated 
results about the FSR of muscle protein directly in a leg muscle. 
Because the sample size of these studies was small, it is difficult 
to compare with the level of FSR. As a result, the precise effects 
of protein or amino acids ingestion are still under debate.
Therefore, we firstly used FSR level of muscle protein 
measured by the same method. The level of FSR was calculated 
by measuring the direct incorporation of phenylalanine or leucine 
into protein by using the precursor-product model [33]. The aim 
of the present study was to identify and combine ten published 
randomized controlled studies that investigated the effects of 
protein or amino acids intake on FSR.
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Fig. 1. Flow chart representing the publication selection process.  Flow  chart 
shows the number of citations retrieved by individual searches and the number of 
trials  included  in  the  review.  FSR,  Fractional  synthesis  rate.
Subjects and Methods
Literature search
We systematically searched PubMed, reviews, and reference 
lists of relevant papers with the strategy of using the term 
“fractional synthesis rate OR muscle protein synthesis OR muscle 
protein anabolism” paired with the following: “dietary protein,” 
“high protein diet,” “essential amino acid,” and “amino acid.”
Study selection 
Searches for English language studies that were published 
between 1 January 1976 and 6 July 2009 were performed in 
PubMed. We selected peer reviewed papers investigated the 
effects of dietary protein on FSR. This selection excluded studies 
without measuring FSR (%/h) in muscle protein. The fractional 
synthetic rate (FSR) of muscle protein was evaluated by 
estimating the direct incorporation of phenylalanine or leucine 
into protein to examine amino acid kinetics in the vastus lateralis 
muscle by using the precursor-product model, which was 
measured before and after the ingestion of protein in elderly or 
young subjects [33]. Participants must have been treated with 
dietary protein for 6 h. Trials evaluating the FSR of muscle 
protein with other methods were also included for systematic 
review but were not selected for meta-analysis, because these 
data could not be combined and compared quantitatively.
Data extraction and statistical analysis
All literature searches were independently reviewed by 3 
authors to identify relevant studies that met the inclusion criteria 
as part of our quality-control process. We extracted only the 
studies including FSR measurement in muscle protein. Disparities 
about qualitative information and quantitative data from each 
study were resolved by discussion. Data on study size, population 
characteristics (age, sex and year), treatment regimen (dose of 
protein and duration of treatment), and change in FSR levels 
were extracted. 
Our primary outcome was the net change in FSR of muscle 
protein due to dietary protein ingestion, which was calculated 
using the DerSimonian-Laird method for a random-effects model 
[34]. Random-effects models were used to calculate the weighted 
mean differences (WMDs), 95% CIs, and corresponding P values 
for heterogeneity. The estimates of the individual studies were 
weighted based on the inverse of the variance, which is related 
to the sizes of the study populations. Between-study heterogeneity 
of treatment effects was assessed using Cochran’s Q test (P <
0.1). The I
2 statistic was also examined, and we considered I
2 
> 50% to indicate significant heterogeneity between the studies 
[35]. Previously defined subgroup analyses and meta-regression 
analyses were performed to explore heterogeneity in effects and 
the influence of study characteristics. Publication bias was assessed 
visually by examining a funnel plot as a function of effect size, 
Egger regression test [36], and failsafe N test [37]. Statistical 
analyses were performed with MIX software (version 1.7; LEON 
BAX) and SPSS software (version 12; SPSS Inc. Chicago).
Results
Search results
A total of 3,644 articles were identified in a search of the 
PubMed and from the reference list of the selected articles. Of 
these, 3,622 articles were excluded because they did not meet 
the inclusion criteria or their interventions were not relevant to 
the purpose of this meta-analysis (such as vitamin C or other 
nutrients intended to improve muscle protein). Full text 
assessment of the 22 potentially relevant articles was identified. 
The most common reasons for exclusion were as follows: protein 
was not admonistered orally but intravenous or intra-arterial 
infusion in 2 studies [32,38] and that levels of fractional synthesis 
rate (FSR) were not reported in 10 studies [28,29,39-46]. Ten 
articles [14,17-24,47] were selected for the meta-analysis and 
were considered by us to meet all the eligibility criteria (Fig. 
1).
Study characteristics
We identified 10 articles [14,17-24,47] with 20 trials and 368 
subjects for inclusion in our study. Characteristics of the studies 
included in the analysis are shown in Table 1. The studies varied 
in size from 6 to 24 subjects. As for the 20 studies that evaluated 
the FSR of muscle protein, 10 trials [17,19-22] investigated the 
effect of protein ingestion consisting of essential amino acids 
in healthy elderly and young subjects. The other 10 trials 
investigated the effect of protein ingestion consisting of various 
amino acids in healthy elderly and young individuals [18,21-24, Hyun-Soo Gweon et al. 377
Table 1. Characteristics of observational studies that evaluated dietary protein 
intake in the included trials 
Reference Age
1)
(yr)
No. of 
subjects
(M/F)
Protein 
dose
(g/kg BW)
Study 
duration
(h)
Control FSR
2)
(%/h)
Paddon-Jones  et al. 
[17]
67 ± 2 7 (3/4) 0.2089 3.5 0.056 ± 0.004
34 ± 4 6 (2/4) 0.2387 3.5 0.064 ± 0.007
Reiu  et al. [18] 70 ± 1 20 (20/0) 0.4704 5 0.055 ± 0.009
Volpi  et al. [19] 71 ± 2 8 (6/2) 0.5405 3 0.050 ± 0.009
30 ± 2 7 (4/3) 0.5556 3 0.044 ± 0.004
Cuthbertson et al. [20] 70 ± 6 24 (24/0) 0.1266 3 0.032 ± 0.005
Katsanos  et al. [14] 67 ± 2 10 (7/3) 0.0821 3.5 0.044 ± 0.003
31 ± 2 8 (4/4) 0.0897 3.5 0.038 ± 0.007
67 ± 2 10 (5/5) 0.0961 3.5 0.048 ± 0.005
29 ± 3 8 (4/4) 0.0874 3.5 0.036 ± 0.004
Paddon-Jones  et al. 
[21]
69 ± 2 7 (4/3) 0.1816 3.5 0.049 ± 0.006
67 ± 2 7 (3/4) 0.2124 3.5 0.056 ± 0.004
Koopman  et al. [22] 75 ± 1 8 (8/0) 1.1156 6 0.043 ± 0.003
20 ± 1 8 (8/0) 1.1130 6 0.060 ± 0.005
Symons  et al. [23] 70 ± 5 10 (5/5) 0.4219 5 0.072 ± 0.004
41 ± 1 10 (5/5) 0.3356 5 0.074 ± 0.005
Welle  et al. [24] 68 ± 1 6 (3/3) 0.8000 6 0.073 ± 0.004
71 ± 2 6 (3/3) 0.3951 6 0.072 ± 0.005
66 ± 1 6 (3/3) 0.2000 6 0.065 ± 0.005
Koopman  et al. [47] 73 ± 1 8 (8/0) 1.1333 6 0.082 ± 0.006
1) Mean ± SE
2) Mean ± SD
M/F,  male/female;  BW,  body  weight
Fig. 2. Random-effect meta-analysis of weight mean differences (95% CI) in 
FSR of muscle protein with dietary protein intake compared with control. Sizes 
of  data  markers  indicate  the  weight  of  each  study  in  the  analysis.
Table 2. Summary of the results on the association of dietary protein intake
on FSR level in the meta-analysis
Variables
1) No. of trials Effect (95% CI) P 
Overall 20 0.025 (0.019, 0.031) < 0.0001
Elderly (69 ± 1) 14 0.024 (0.017, 0.031)
Young (31 ± 3) 6 0.027 (0.018, 0.037)  
1) Mean ± SE  (all  such  values)
Table 3. Characteristics of subgroups according to the dietary protein intake
Low protein
(≤0.80 g/kg BW)
1)
High protein
(> 0.80 g/kg BW)
1
Overall Elderly Young Overall Elderly
A g e  ( y ) 5 8±4 6 9±1 3 3±2 5 9±1 3 7 2±1 3
Protein dose
(g/kg BW
2)
0.27 ± 0.04 0.27 ± 0.05 0.26 ± 0.09 1.04 ± 0.08 1.02 ± 0.08
Study duration 
(h)
4.0 ± 0.3 4.1 ± 0.3 3.7 ± 0.3 5.8 ± 0.1 5.8 ± 0.1
1) Mean ± SE  (all  such  values)
BW:  body  weight
47]. The average age of the participants varied from 20 to 73 
y. Doses of protein in the included studies ranged from 0.12 
to 1.13 g/kg of body weight during trials, and the treatment 
duration varied from 3 h to 6 h. Protein was ingested to one 
meals in the study period of 11 trials [14,17,20,21,23], and 
consumed as small liquid meals or boluses which divided by 
periods (12 to 18 times) in 9 trials [18,19,22,24,47].
Effects of short-term protein ingestion on FSR
Twenty trials evaluated the effect of short-term protein 
ingestion on FSR level of muscle protein. The work of 
Paddon-Jones  et al. [21] was separated into 2 trials (effect of 
muscle protein synthesis in elderly human following isocaloric 
ingestion of amino acids or whey protein) for analysis. Because 
one study [24] reported as a unit of percent of FSR per day, 
the data was transformed as the unit per hour. Two studies [24,47] 
reported FSR level of the protein ingestion and exercise. One 
study reported FSR level of 2.5 g to 40 g essential amino acids 
(EAAs). We extracted the FSR data from 10 g EAAs for 
meta-analysis [20]. 
First, the data were pooled from 10 studies. FSR levels were 
significantly higher in the protein ingested subjects than in the 
control ingested subjects (20 comparisons, 368 participants; 
WMD: 0.025%/h; 95%CI: 0.019-0.031; P < 0.0001) (Fig. 2). 
Significant heterogeneity for this outcome was found (heterogeneity 
Q = 1253, I
2 =9 8 % ,  P < 0.0001). The FSR level of the healthy 
elderly and young subjects is shown in Table 2. When studies 
of elderly and young subjects on the FSR of muscle protein were 
analyzed, we determined that the FSR level was 0.024%/h (95% 
CI, 0.017-0.031; P< 0.0001) in the elderly subjects (14 comparisons, 
274 participants) and 0.027%/h (95%CI, 0.018-0.037; P<0 . 0 0 1 ) 
in the young subjects (6 comparisons, 94 participants). FSR levels 
were higher in the young subjects (13%) than in the elderly 
subjects (Table 2). 
The sources of heterogeneity were investigated by meta- 
regression methods. Meta-regression analysis of the data showed 
that the protein dose of FSR was positive related to effect size 
(regression coefficient = 0.108%/h; 95%CI: 0.035, 0.182; P =
0.009), which explained significant heterogeneity of the effect. 
The study duration (range: 3~6 h/ test period), and the average 
age of the participants were not effect modifiers.
Subgroup analyses were done in order to identify sources of 
heterogeneity. Rand and colleagues proposed that the recommended 
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Table 4. Effect of protein diet intake on FSR level stratified by previously defined
study characteristics
Variables
2) Trials Effect (95% CI) P
1)
n
Protein dose (g/kg BW)
≤0.80  16 0.027 (0.021, 0.034) 0.01
Elderly 11 0.027 (0.019, 0.035)
Young 5 0.029 (0.017, 0.040)
> 0.80, quartile 4 4 0.016 (0.004, 0.029)
Protein dose (g/kg BW)
< 0.13, quartile 1 5 0.018 (0.005, 0.032) 0.01
≥0.13 15 0.025 (0.024, 0.027)
Study duration (h)
< 5.5, low median 14 0.028 (0.021, 0.035) 0.71
≥5.5, high median 6 0.018 (0.009, 0.026)
Age (y)
< 67, low median 11 0.025 (0.017, 0.032) 0.66
≥67, high median 9 0.025 (0.016, 0.035)
1) P  for  difference  between  strata  (student’s  t t e s t )
2) Different cutoffs of FSR for the subgroup analysis were set based on the quartiles 
and  medians  for  all  trials. 
BW:  body  weight
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Fig. 3. Funnel plot of all individual studies in the meta-analysis. S t u d ie s  th a t 
evaluated the effect of protein ingestion on FSR were plotted with mean difference 
on  the  horizontal  axis  and  the  inverse  standard  error  along  the  vertical  axis.
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Fig. 4. Funnel plot of studies in the meta-analysis with the FSR level (≤0.80 
g) of low protein dose. Studies that evaluated the effect of protein ingestion on 
FSR  were  plotted  with  mean  difference  on  the  horizontal  axis  and  the  inverse 
standard  error  along  the  vertical  axis.
years and older is 0.8 g/kg/day [48]. Because of the lack of 
reference ranges for protein dose, we predefined the first to third 
quartiles as low protein dose group (≤ 0.80 g/kg BW) for all 
included trials, whereas the fourth quartile (> 0.80 g/kg BW) was 
assigned as the high group. Characteristics of the subgroups are 
shown in Table 3. Protein intake significantly increased the level 
of FSR when the protein dose was ≤0.80 g/kg BW (16 trials, 
308 participants; WMD: 0.027%/h; 95%CI: 0.019-0.031; P <
0.0001), but had nonsignificant effect on FSR if the protein dose 
was > 0.80g/kg BW (4 trials, 60 participants; WMD: 0.016%/h; 
95%CI: 0.004-0.029; P = 0.98) (Table 4). When effect size of 
low protein dose on the FSR of muscle protein was analyzed 
in elderly and young subjects, we determined that the FSR level 
was 0.027%/h in the elderly subjects (11 comparisons, 230 
participants) and 0.029%/h in the young subjects (5 comparisons, 
78 participants). FSR levels were not different between the young 
and elderly subjects (7% difference). The FSR level of muscle 
protein was effective when protein dose was low, as well as the 
trend was also statistically significant when < 0.13 g/kg BW 
(cutoff for first quartile) was used as cutoffs or thresholds for 
the subgroup analysis. The FSR was continuously increased until 
the amount of protein dose was 0.08 to 0.80 g/kg BW (Table 4). 
A sensitivity analysis according to other participant characteristics 
and study design features found that there were no effects due 
to mean age of the study population, or study duration on the 
estimated change in FSR of muscle protein due to protein 
ingestion (Table 4).
Publication bias
Funnel plot had the expected asymmetric funnel shape (Fig. 
3 and 4). Egger test for publication bias (P= 0.72) indicated that 
there was little or no publication bias in our analysis. A statistical 
analysis of the dietary protein intake and the post-exercise did 
not suggest any significant publication bias (Egger test, P=0 . 9 5 
for subgroup of the protein intake; Egger test, P = 0.45 for 
subgroup of the post-exercise; Egger test, P= 0.97 for subgroup 
of low protein dose). A fail-safe N test indicated that it would 
take 8096 (for all studies), 8096 (for the dietary protein intake 
subgroup), or 5794 (for low protein dose subgroup) unpublished 
studies that would be required to change the results to a 
nonsignificant effect.
Discussion
Compared with control, short-term protein ingestion resulted Hyun-Soo Gweon et al. 379
in a substantial improvement in FSR level of muscle protein. 
Overall effect size of FSR was higher in the young subjects than 
in the elderly, but that of protein intake was not different between 
the young and elderly subjects. There was significantly 
heterogeneity between studies in the overall analysis. Therefore, 
we considered that the characteristics of subjects and study design 
may have influenced the results of these studies. An evidence 
from meta-regression suggested that the heterogeneity was 
explained by the protein dose, and indicated that protein dose 
was positively related to the effect size. The FSR was 
continuously increased until amount of protein dose was 0.08 
to ≤0.80 g/kg BW (Table 4). In other words, as protein dose 
increased to > 0.80 g/kg BW, the level of FSR was gradually 
attenuated.
Our subgroup analysis showed that the level of FSR was 
increased when protein dose was low, but decreased when protein 
dose was high. These data suggest that the protein ingestion was 
able to improve the muscle protein synthesis in both the healthy 
elderly and young individuals. The consistent results identified 
by the meta-regression and subgroup analysis enhance confidence 
of the contrasting results in the different subgroups and suggest 
that protein dose largely influenced the level of FSR. 
The age-related loss of muscle cells and strength occurs at 
a rate of approximately 10% per decade after 50 years of age 
[45]. A decline of skeletal muscle mass with aging is attributed 
to a disruption in regulation of muscle protein synthesis and/or 
breakdown [16]. Recent studies [29,41,44,46] have shown that 
dietary protein or amino acids ingestion improves muscle protein 
synthesis, which is similar between young and old men; however, 
the response is delayed with aging. Specifically, inappropriate 
or insufficient protein intake in the elderly did not induce the 
muscle protein synthesis. Further, inappropriate or insufficient 
nutritional intake may impair anabolic signaling in skeletal 
muscle tissue, which may be a key factor of sarcopaenia 
[1,2,8,20,31]. More recent study [49] has shown that the 
phosphorylation of p70 ribosomal S6 kinase (p70S6K) and 
eukaryotic initiation factor 4E binding protein 1 (4EBP1) was 
blunted in older men. Both p70S6K and 4EBP1, downstream 
effectors of mTOR signaling, are key intracellular pathway 
coordinating signals in the regulation of protein synthesis. They 
play a key regulatory role in the regulation of translation 
initiation [50]. Drummond et al. [41] suggested that unresponsive 
ERK1/2 signaling and AMPK activation in old muscle may be 
playing a role in the delayed activation of muscle protein 
synthesis. The mechanism whereby protein intake may improve 
FSR, especially when protein dose is low, remains uncertain. 
It has been reported that muscle from elder individuals is 
resistant to the anabolic effects of amino acids. Wolfe and 
coworkers have extensively investigated that muscle protein 
synthesis is stimulated in young and elder subjects when protein 
or EAAs are ingested [14,17,19,29,51]. Paddon-Jones et al. [17] 
have shown that the ingestion of essential amino acids (EAA) 
stimulates muscle protein synthesis to a similar extent in young 
and old individuals. Aged muscle has a decreased sensitivity and 
responsiveness to amino acids at physiological concentrations but 
can still respond if the increase of aminoacidaemia is large 
enough [17,19]. It has recently reported that among amino acids, 
branched chain amino acids and especially leucine supplementation 
improve muscle protein synthesis in elderly men independently 
of hyperaminoacidaemia [18]. Symons et al. [23] clearly shows 
that aging does not impair the ability to acutely synthesize muscle 
protein after ingestion of a common protein-rich food. 
However, recent study has reported that long-term leucine 
supplementation does not increase muscle mass or strength in 
healthy elderly men [40]. Koopman et al. [47] showed that 
co-ingestion of leucine with protein does not further augment 
post-exercise muscle protein synthesis rates in elderly men. Welle 
et al. [24] also showed that high-protein meals do not enhance 
myofibrillar synthesis after resistance exercise in 62 to 75-yr-old 
men and women.
These different results can be due to the quantity and the quality 
of ingested protein. Specifically, in the elderly, inappropriate or 
insufficient protein intake may impair anabolic signaling in 
skeletal muscle tissue [1,2,8,20,31]. It has been shown that aging 
is not associated with an ability of skeletal muscle to respond 
to low doses (~7.5 g) of EAAs whereas higher doses (10-15 
g) are able to stimulate muscle protein synthesis to a similar 
extent as the young [17,21,31]. Further, the proportional FSR/ 
EAA dose-response is responsible for stimulating muscle protein 
synthesis while the supplementation of non-essential amino acids 
does not further enhance the anabolic stimulus. It is important 
to supply leucine to small bolus of EAAs in enhancing the ability 
of aged muscle. Rieu et al. [18] reported that leucine- 
supplemented meals may improve or normalize muscle protein 
synthesis in aging muscle. Katsanos et al. [14] has shown that 
addition of supplemental leucine to a bolus of EAAs in aged 
humans increases muscle protein synthesis. A repeated supple-
mentation of EAAs at short-term can improve muscle protein 
synthesis and prevent a loss of muscle protein with aging. 
Consequently, dietary supplementation with sufficient EAAs 
alone may provide a practical and efficient means of stimulating 
protein synthesis in the elderly.
In the other hand, the FSR in this study was continuously 
increased until amount of protein dose was 0.08 to ≤0.80 g/kg 
BW (Table 4). The Estimated Average Requirement (EAR) of 
0.66 g protein/kg body weight/d and the Recommended Dietary 
Allowance (RDA) 0.80 g protein/kg body weight/d are deemed 
the same for all apparently healthy men and women aged ≥19 
y [52]. However, it has not explained whether the RDA of 0.80 
g protein/kg body weight/d in the elderly is adequate. Level of 
FSR in this study is well consistent with level of the RDA in 
the elderly.
There are distinct differences in protein response between the 
young and the elderly. These differences can be the result of 
changes in signaling pathways over the course of decades. In 
line with this, there are also indications that protein digestion 380 Protein intake increases muscle protein in elderly
and absorption rates are different between the young and the 
old. These findings provide indirect evidence suggesting that the 
efficiency of protein synthesis after a meal may be impaired in 
older populations. Gut physiology and nutritional status in the 
elderly can be changed by the rate of gastric emptying and 
first-pass splanchnic uptake [53]. Symons et al. [23] has shown 
that in comparison with the peak concentrations of the more 
rapidly digested and absorbed amino acids or whey protein 
supplements, peak concentrations of AAs in both young and elder 
groups occurred more slowly after beef ingestion. This difference 
may be due to the smaller body size (lean and total mass) of 
the elderly than of the young subjects, consequently representing 
a proportionally greater nutrient intake for physically smaller 
subjects. One study [43] indicated that a short-term high-protein 
diet does not augment muscle protein synthesis. Because subjects 
with a high protein dose may already have the amount of sufficient 
muscle protein synthesis, the remained protein transformed to 
a fuel for energy production [15,32]. Notwithstanding, ingestion 
of essential amino acid (EAA) results in a change from net 
muscle protein degradation to net muscle protein synthesis after 
heavy resistance exercise [39,41,42]. One study [28] documented 
that branched-chain amino acid supplementation to soy protein 
enhances whole-body protein synthesis in patients with chronic 
wasting diseases (eg, chronic obstructive pulmonary disease), but 
not in the healthy elderly. Furthermore, protein source (e.g. whey, 
casein, vegetable or animal) and type (intact, hydrolyzed or 
specific peptide sequences) can result in different responses in 
young and old subjects [17,21-23,29-31]. This difference is 
considered to be of high biological value according to source 
of dietary protein. Ingestion of higher quality of protein or amino 
acids, as well as higher quantity of EAAs or leucine with EAAs 
is a good method to prevent muscle loss in the elderly. 
Thus, the continuous sufficient protein intake or the combination 
of resistance exercise and protein ingestion should be a useful 
strategy to improve the physical function of aging muscle through 
muscle protein synthesis. We suggest that protein ingestion can 
be a good alternative to combat muscle loss. Ultimately, this 
result appears to support the idea that we should provide 
sufficient protein to the elderly as well as all individuals who 
would need muscle protein synthesis. In the near future, long- 
term intervention studies should be warranted to address the 
efficacy of protein and/or amino acids supplementation as an 
interventional strategy to attenuate the loss of skeletal muscle 
mass with ageing.
The present study had several potential limitations. First, only 
4 trials were combined for analysis in the high protein dose 
group. When the high protein dose (> 0.80 g/kg BW) was used 
as cutoffs for subgroup analysis, the lack of statistical significance 
might be due to the small number of studies. Second, because 
significant heterogeneity was observed in the effect size of all 
studies and in the subgroup with low protein dose, both funnel 
plots and Egger tests did not provide sufficient evidence against 
a publication bias. However, a fail-safe N test indicated that it 
would take 8096 (for the dietary protein intake subgroup), or 
5794 (for low protein dose subgroup). The existence of that many 
unpublished studies is improbable; hence, this fail-safe N added 
greatly to the confidence of the results of our meta-analysis. 
Third, the mean study duration and mean age were statistically 
different between groups with high and low protein intakes 
(Table 4) and varied largely in all studies. The potential influence 
of these factors was estimated by the sensitivity analysis and 
the meta-regression analysis, which indicated that the mean study 
duration (range: 3-6 h) and the average age of the participants 
were not effect modifiers. It is an interesting point that the FSR 
was effective when the need of additional protein (≤0.80 g/kg 
BW) for muscle protein synthesis was accepted, which suggests 
that daily protein intakes may be enough to induce a favorable 
effect in the elderly. Other explanations may be that the sample 
size was not large enough, which resulted in a lack of power 
to detect the effect. Thus, additional studies are needed. 
This meta-analysis suggests that the FSR level of muscle 
protein is likely to be benefitted from short-term protein intake 
in the healthy young as well as elderly subjects. This beneficial 
effect seems to be dose-dependent when the dose of protein 
ranges from 0.08 to 0.80 g/kg BW. Future research should focus 
on greater quantity trials with longer follow-ups to support the 
certainty regarding the clinical effects. 
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